The most common side effects of NUCALA include: headache, injection site reactions (pain, redness, swelling, itching, or a ...
Chronic obstructive pulmonary disease (COPD) makes it hard to breathe. Narrowed airways can make you cough, wheeze, and feel short of breath. It can affect how you exercise, work, and do other daily ...
Julia Slejko, PhD, and Robert Reed, MD, discuss findings of their recent study on patient-reported value in chronic obstructive pulmonary disease (COPD) treatment management. Chronic obstructive ...
Ohtuvayre (ensifentrine), a drug approved in 2024 to treat chronic obstructive pulmonary disorder (COPD), is receiving high marks from doctors and patients. Ohtuvayre is the first new inhaled COPD ...
A new COPD drug, developed by Verona Pharma, was approved by the FDA Wednesday. The drug, ensifentrine, is the first new type of maintenance treatment for COPD in over a decade. In clinical trials, ...
Woman’s World has affiliate partnerships. We receive compensation when you click on a link and make a purchase. Learn more! Sure, having a cold or respiratory infection can temporarily make it harder ...
AJMC®: How is COPD definitively diagnosed in clinical practice, and how does this disease create a clinical burden on patients and caregivers? Dr Rali: COPD diagnosis requires both clinical context ...
Please provide your email address to receive an email when new articles are posted on . Remodeling may include more smooth muscle mass and epithelial cell shedding. Macrolides, vaccination and ...
Chronic obstructive pulmonary disease (COPD) and acute bronchitis both cause lung irritation and inflammation. They can trigger similar symptoms, including coughing, chest pain, and fatigue. Acute ...
It seems patient satisfaction is low when it comes to their chronic obstructive pulmonary disease (COPD) treatment, according to a recent report out from consultancy Phreesia Life Sciences. When ...
Please provide your email address to receive an email when new articles are posted on . During a 5-year period, 45,079 of 156,462 patients with GOLD A/B COPD progressed to GOLD E. More patients moved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results